Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 11—November 2014
Research

Respiratory Viruses and Bacteria among Pilgrims during the 2013 Hajj

Figures
Tables
Article Metrics
101
citations of this article
EID Journal Metrics on Scopus
Author affiliations: Aix Marseille Université, Marseille, France (S. Benkouiten, R. Charrel, K. Belhouchat, T. Drali, A. Nougairede, N. Salez, P.-E. Fournier, D. Raoult, P. Brouqui, P. Parola, P. Gautret); Institut Hospitalo-Universitaire Méditerranée, Marseille (S. Benkouiten, R. Charrel, A. Nougairede, N. Salez, P.-E. Fournier, D. Raoult, P. Brouqui, P. Parola, P. Gautret); Saudi Ministry of Health, Riyadh, Saudi Arabia (Z.A. Memish, M. al Masri); Alfaisal University College of Medicine, Riyadh (Z.A. Memish)

Cite This Article

Abstract

Pilgrims returning from the Hajj might contribute to international spreading of respiratory pathogens. Nasal and throat swab specimens were obtained from 129 pilgrims in 2013 before they departed from France and before they left Saudi Arabia, and tested by PCR for respiratory viruses and bacteria. Overall, 21.5% and 38.8% of pre-Hajj and post-Hajj specimens, respectively, were positive for ≥1 virus (p = 0.003). One third (29.8%) of the participants acquired ≥1 virus, particularly rhinovirus (14.0%), coronavirus E229 (12.4%), and influenza A(H3N2) virus (6.2%) while in Saudi Arabia. None of the participants were positive for the Middle East respiratory syndrome coronavirus. In addition, 50.0% and 62.0% of pre-Hajj and post-Hajj specimens, respectively, were positive for Streptococcus pneumoniae (p = 0.053). One third (36.3%) of the participants had acquired S. pneumoniae during their stay. Our results confirm high acquisition rates of rhinovirus and S. pneumoniae in pilgrims and highlight the acquisition of coronavirus E229.

More than 2 million Muslims gather annually in Saudi Arabia for a pilgrimage to the holy places of Islam known as the Hajj. The Hajj presents major public health and infection control challenges. Inevitable overcrowding within a confined area with persons from >180 countries in close contact with others, particularly during the circumambulation of the Kaaba (Tawaf) inside the Grand Mosque in Mecca, leads to a high risk pilgrims to acquire and spread infectious diseases during their time in Saudi Arabia (1), particularly respiratory diseases (2). Respiratory diseases are a major cause of consultation in primary health care facilities in Mina, Saudi Arabia, during the Hajj (3). Pneumonia is a leading cause of hospitalization in intensive care units (4).

Numerous studies have shown a high prevalence of respiratory symptoms among pilgrims (57). Respiratory viruses, especially influenza virus, are the most common cause of acute respiratory infections among pilgrims (811). We recently reported the acquisition of rhinovirus (5) and Streptococcus pneumoniae infections (12) by French pilgrims during the 2012 Hajj season and highlighted the potential for spread of these infections to home countries of pilgrims upon their return. However, none of the French pilgrims were positive for Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 (13) and 2013 (14).

In this study, we collected paired nasal and throat swab specimens from adult pilgrims departing from Marseille, France to Mecca, Saudi Arabia, for the 2013 Hajj season. The primary objective was to determine the prevalence of the most common respiratory viruses and bacteria upon return of pilgrims from the Hajj. The secondary objective was to evaluate the potential yearly variation of the acquisition of these respiratory pathogens by comparing results from the 2012 and 2013 Hajj seasons.

Methods

Participants

Pilgrims who planned to participate in the 2013 Hajj were recruited on September 15, 2013, at a private specialized travel agency in Marseille, France, which organizes travel to Mecca. Potential participants were asked to participate in the study on a voluntary basis if they were ≥18 years of age and were able to provide consent.

Study Design

In this prospective cohort study, participants were sampled and followed up before departing from France (on October 2, 2013) and immediately before leaving Saudi Arabia (on October 24, 2013). Upon inclusion in the study, participants were interviewed by Arabic-speaking investigators who used a standardized pre-travel questionnaire that collected information on the demographic characteristics and medical history of each participant. A post-travel questionnaire that collected clinical data and information on vaccination status and compliance with preventive measures was completed during a face-to-face interview 2 days before the pilgrims returned to France by a single investigator who joined the pilgrims after the Hajj. Health problems that occurred during the pilgrims’ stay were also recorded by a physician who traveled with them during the entire stay in Saudi Arabia, including during the rituals.

Subjective fever was defined as a feverish feeling according to the pilgrims’ report. Influenza-like illness (ILI) was defined as the presence of cough, sore throat, and subjective fever (15). The study protocol was approved by the Aix Marseille Université institutional review board (July 23, 2013; reference no. 2013-A00961–44) and by the Saudi Ministry of Health Ethical Review Committee. The study was performed in accordance with the good clinical practices recommended by the Declaration of Helsinki and its amendments. All participants gave written informed consent.

Respiratory Specimens

Paired nasal and throat swab specimens were collected from each participant by using rigid cotton-tipped swab applicators (Medical Wire and Equipment, Corsham, UK) 10 days (September 22, 2013) before participants departed from France (pre-Hajj specimens) and only 1 day (October 23, 2013) before they left Saudi Arabia (post-Hajj specimens). Nasal and throat swab specimens collected from participants were placed in viral transport media (Virocult and Transwab, respectively; Sigma, St. Louis, MO, USA) at the time of collection and kept at 20°C before being transported to a laboratory in Marseille for storage at −80°C within 48 h of collection.

Detection of Respiratory Viruses

Nasal swab samples were independently tested as described (5) for influenza virus A/H3N2 (16), influenza B virus (16), influenza C virus (17), and A(H1N1)pdm09 virus (18); human adenovirus (19); human bocavirus (20), human cytomegalovirus (21); human coronaviruses (HCoVs); human enterovirus (22); human metapneumovirus (23); human parainfluenza viruses (HPIVs); human parechovirus (24); human respiratory syncytial virus (25); and human rhinovirus (HRV) (26) by using real-time reverse transcription PCRs. HCoVs and human HPIVs were detected by using an HCoV/HPIV R-Gene Kit (Argene/bioMérieux, Marcy l’Etoile, France) (27). HCoV-positive samples were then genotyped by using the FTD Respiratory Pathogens 21 Kit (Fast Track Diagnostics, Luxembourg, Luxembourg).

Detection of Respiratory Bacteria

Throat swab samples were independently tested as described (12) by using quantitative real-time PCRs for Streptococcus pneumoniae, Neisseria meningitidis, Bordetella pertussis, and Mycoplasma pneumoniae. Sequences of all primers and probes have been reported (28). In the present study, reactions were performed by using a 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA).

Statistical Analysis

The Pearson χ2 and Fisher exact tests, as appropriate, were used to analyze categorical variables. Statistical analyses were performed by using SPSS software package version 17 (SPSS Inc., Chicago, IL, USA). p values ≤0.05 were considered significant.

Results

Characteristics of Study Participants

A total of 129 persons were invited to participate in the study. All persons agreed to participate in the study and responded to the pre-travel questionnaire. The participants were 77 women (59.7%) and 52 men (40.3%) who had a mean (SD) age of 61.7 (9.8) years (age range 34–85 years) (Table 1). Although most (94.6%) participants were born in northern Africa, most (94.5%) had lived for years in Marseille or the surrounding cities. More than half of the participants (52.7%) reported having ≥1 chronic disease, as described (14).

Clinical Features

All post-travel questionnaires were completed. During the 3-week stay in Saudi Arabia (October 3–24, 2013), most (90.7%) pilgrims had ≥1 respiratory symptom, including cough (86.8%), sore throat (82.9%), rhinorrhea (72.1%), myalgia (50.4%), fever (49.6%), and dyspnea (21.7%), and 47.3% met the criteria for self-reported ILI (41.3% in 2012 vs. 47.3% in 2013; p = 0.325). Onset of respiratory symptoms peaked in the second week (week 41) after the arrival of the pilgrims in Mecca and decreased thereafter. However, 90 (69.8%) pilgrims still had respiratory symptoms before leaving Saudi Arabia at the time of sampling (week 43). Only 1 pilgrim (0.8%) was hospitalized during the stay in Saudi Arabia (for undocumented pneumonia). No deaths occurred.

Regarding preventive measures, 51.2% of participants reported receiving pneumococcal vaccination (Pneumo 23) in the past 5 years, which was significantly higher than the rate in 2012 (35.9% in 2012 vs. 51.2% in 2013; p = 0.013). None had received the 2013 influenza vaccine before departing for the Hajj, but 44.2% reported having received the seasonal influenza vaccine in 2012 (31.8% among participants <65 years of age vs. 65.8% among participants >65 years of age; p = 0.001). During the stay in Saudi Arabia, 53.5% of pilgrims reported either frequent use (9.3%) or occasional use (44.2%) of facemasks; 93.0% used disposable handkerchiefs; 49.6% reported frequent handwashing; and 67.4% used hand sanitizer. ILI symptoms were less frequently reported by persons who reported receiving the influenza vaccine in 2012 compared with reports by unvaccinated persons (34.1% vs. 61.5%, respectively; p = 0.009) (odds ratio 0.32, 95% CI 0.14–0.76). In contrast, none of the other preventive measures was found to be effective in preventing ILI symptoms during the stay in Saudi Arabia.

Detection of Respiratory Viruses

Figure 1

Thumbnail of Patterns of respiratory viruses detected among 64 pilgrims who were positive for viruses during the study period before departing from France and before leaving Saudi Arabia, 2013 Hajj. FLUA, influenza A(H3N2) virus; FLUB, influenza B virus; FLUC, influenza C virus; A/H1N1, A(H1N1)pdm09 virus; HAdV, human adenovirus; HBoV, human bocavirus; HCMV, human cytomegalovirus; EV, human enterovirus; HMPV, human metapneumovirus; HPeV, human parechovirus; HPIV, human parainfluenza virus; HRV,

Figure 1. Patterns of respiratory viruses detected among 64 pilgrims who were positive for viruses during the study period before departing from France and before leaving Saudi Arabia, 2013 Hajj. FLUA, influenza A(H3N2)...

Pre-Hajj and post-Hajj nasal swab specimens were obtained from 121 (93.8%) and 129 (100%) participants, respectively. A total of 26 (21.5%) of 121 pre-Hajj specimens tested were positive for ≥1 virus compared with 50 (38.8%) of 129 post-Hajj specimens tested (p = 0.003) (Table 2). Moreover, 36 (29.8%) participants had acquired ≥1 virus during the stay in Saudi Arabia (Figure 1). The prevalence of human coronavirus E229 (HCoV-E229) was significantly higher in post-Hajj specimens than in pre-Hajj specimens (12.4% vs. 0%; p<0.001). A high prevalence of HRV was observed in pre-Hajj and post-Hajj specimens (14.0% and 14.7%, respectively; p = 0.88). Of 19 participants whose post-Hajj specimens were positive for HRV, 17 (89.5%) had acquired the infection during their stay in Saudi Arabia (Figure 1).

The prevalence of influenza A and B viruses was significantly higher in post-Hajj specimens than in pre-Hajj specimens (7.8% vs. 0%; p = 0.002); further details are described elsewhere (14). Coronaviruses HKU1, NL63, and OC43; human enterovirus; human metapneumovirus; HPIV; and human respiratory syncytial virus were also acquired during the stay in Saudi Arabia by a low proportion of participants (Table 2). Of 50 participants whose post-Hajj specimens were positive for ≥1 respiratory virus, 43 (86.0%) reported ≥1 respiratory symptom during their stay in Saudi Arabia, of whom 37 (86.0%) still had respiratory symptoms at the time of sampling. Also, of 79 participants whose post-Hajj specimens were negative for respiratory viruses, 74 (93.7%) reported ≥1 respiratory symptom during their stay Saudi Arabia, of whom 53 (71.6%) still had respiratory symptoms at the time of sampling. None of the preventive measures was found to be effective in preventing respiratory viruses in post-Hajj specimens.

Detection of Respiratory Bacteria

Pre-Hajj and post-Hajj throat swab specimens were obtained from 126 (97.7%) and 129 (100%) participants, respectively. None of the participants were positive for N. meningitidis, B. pertussis, or M. pneumoniae at any point in the study period (Table 2).

Figure 2

Thumbnail of Detection of Streptococcus pneumoniae among 92 pilgrims who were positive for viruses during the study period before departing from France and before leaving Saudi Arabia, 2013, Hajj.

Figure 2. Detection of Streptococcus pneumoniae among 92 pilgrims who were positive for viruses during the study period before departing from France and before leaving Saudi Arabia, 2013 Hajj.

A total of 63 (50.0%) of 126 pre-Hajj specimens tested and 80 (62.0%) of 129 post-Hajj specimens tested were positive for S. pneumoniae (p = 0.053) (Table 2; Figure 2). Of 80 participants whose post-Hajj specimens were positive for S. pneumoniae, 29 (36.3%) had acquired the infection during their stay in Saudi Arabia (Figure 2). In addition, of 63 participants whose pre-Hajj specimens were positive for S. pneumoniae, 12 (19.0%) subsequently had post-Hajj specimens that were negative for S. pneumoniae (Figure 2), of whom 10 (83.3%) reported having received antimicrobial drugs during their stay in Saudi Arabia: 7 received amoxicillin, 2 received amoxicillin and ciprofloxacin, and 1 received azithromycin. Of 80 participants whose post-Hajj specimens were positive for S. pneumoniae, 73 (91.2%) reported ≥1 respiratory symptom during their stay in Saudi Arabia, of whom 56 (76.7%) still had respiratory symptoms at the time of sampling.

Among 66 participants who reported having received a pneumococcal vaccination in the 5 years before traveling to Saudi Arabia, 37 (56.1%) had post-Hajj specimens that were positive for S. pneumoniae. The prevalence of S. pneumoniae in post-Hajj specimens was significantly lower in persons who reported using hand sanitizer during their stay in Saudi Arabia than in remaining participants (55.2% vs. 76.2%; p = 0.021) (odds ratio 0.39, 95% CI 0.17–0.88) and slightly lower in persons who reported more frequent handwashing than usual during their stay in Saudi Arabia than in persons who reported usual handwashing (54.7% vs. 69.2%; p = 0.08).

Of 80 participants whose post-Hajj specimens were positive for S. pneumoniae, 27 (33.8%) were co-infected with ≥1 virus (Figure 2). Of 49 participants whose post-Hajj specimens were negative for S. pneumoniae, 23 (46.9%) were infected with ≥1 virus (33.8% vs. 46.9%; p = 0.14) (Figure 2).

Discussion

For the second consecutive year, we conducted a prospective longitudinal study of respiratory viruses and bacteria in respiratory specimens collected from a single cohort of pilgrims before departing from Marseille, France, to Mecca, Saudi Arabia, for the Hajj and immediately before leaving Saudi Arabia. By collecting samples from pilgrims before their departure from Saudi Arabia, we were able to rule out acquisition of infections acquired as a result of travel through the international airports of Jeddah, Saudi Arabia, and Istanbul, Turkey, as part of the return trip to Marseille. Close monitoring for respiratory symptoms and compliance with preventive measures was also performed by the investigators accompanying the group.

In this study, we confirmed that performing the Hajj pilgrimage is associated with an increased occurrence of respiratory symptoms in most pilgrims; 8 of 10 pilgrims showed nasal or throat acquisition of respiratory pathogens. This acquisition may have resulted from human-to-human transmission through close contact within the group of French pilgrims because many of them were already infected with HRV or S. pneumoniae before departing from France. Alternatively, the French pilgrims may have acquired these respiratory pathogens from other pilgrims, given the extremely high crowding density to which persons from many parts of the world are exposed when performing Hajj rituals. Finally, contamination originating from an environmental source might have played a role. Sequencing of these pathogens would be required to determine how often new infections were acquired during the stay in Saudi Arabia. However, detection of nasal carriage of coronaviruses other than MERS-CoV and influenza A and B viruses in only the post-Hajj specimens supports the hypotheses that infection occurred during the Hajj.

We confirmed the predominance of HRV and S. pneumoniae among pathogens acquired during the pilgrims’ stay (5,12). We also highlighted acquisition of coronaviruses other than MERS-CoV, most notably HCoV-E229, by pilgrims during the 2013 Hajj pilgrimage. In 2012 and 2013, results of screening for MERS-CoV infection in different cohorts of pilgrims, including the present cohort, were negative (13,14,29). Finally, we found that compared with acquisition of HRV and HCoV-E229, influenza viruses were acquired at a lower frequency among pilgrims.

The present study is a continuation of our previous study in 2012 (5). We extended the investigation to additional viruses, including human bocavirus, human cytomegalovirus, coronaviruses, human parechoviruses, and HPIV, and showed a high frequency of HCoV-E229 infection in pilgrims returning from the Hajj. The prevalence of HRV was lower in 2012 than in 2013, both before departing from France (3.0% in 2012 vs. 14.0% in 2013; p = 0.001) and before leaving Saudi Arabia (8.4% in 2012 vs. 14.7% in 2013; p = 0.092). However, samples that were obtained from pilgrims before departing from France during the 2012 study were stored at room temperature (20°C) for ≤30 days before being processed. This protocol may have resulted in degradation of genetic material, which probably contributed to underestimation of frequencies of infection in 2012. In 2013, all samples collected during the study period were stored at −80°C within 48 h of collection.

The prevalence of S. pneumoniae was also significantly lower in 2012 than in 2013 before pilgrims departed from France (7.3% vs. 50.0%; p<0.001) and before they left Saudi Arabia (19.5% vs. 62.0%; p<0.001). However, in the 2012 study, nasal swab specimens were collected from participants instead of throat swab specimens, which were used in the 2013 study. In addition, the period of the storage of samples before freezing differed between the 2012 and the 2013 studies, as mentioned earlier in this report.

Our results confirm that various respiratory viruses might be acquired by pilgrims during their stay in Saudi Arabia and introduced into home countries of pilgrims on their return, thus contributing to potential international spread of these viruses. However, detection of other human coronaviruses does not enable any conclusions regarding MERS-CoV, for which the available data to date, although limited, indicate different epidemiologic characteristics. We could not demonstrate whether pathogens detected in respiratory specimens were responsible for observed symptoms because nasal carriage was observed in asymptomatic pilgrims in certain instances, and symptoms might have resulted from infection by pathogens that were not investigated in our study. In future studies, checking pilgrims at more frequent intervals might provide useful information. Nevertheless, we believe that Hajj cough likely results from infection of the respiratory tract by various respiratory viruses, including HRV and HCoV-E229, which are known to cause mild or serious lower respiratory tract infections (30,31). However, our results cannot be extrapolated to all pilgrims. A large-scale study based on a similar design and conducted in a large number of pilgrims from many countries would be useful.

We found that pilgrims who had received influenza vaccine in 2012 were less likely to report ILI symptoms during their stay in Saudi Arabia in 2013. Thus, availability of seasonal influenza vaccine for all persons attending the Hajj is crucial. Vaccination with a conjugate pneumococcal vaccine should be considered for persons with medical risk factors for invasive pneumococcal disease. In addition, use of hand sanitizer during the stay in Saudi Arabia was reported by more than two thirds of pilgrims in our survey and was associated with a lower prevalence of S. pneumoniae carriage. Interventional studies are urgently needed that evaluate efficacy of influenza and pneumococcal vaccines and use of hand sanitizer and closely monitor respiratory symptoms and carriage of respiratory pathogens in large cohorts of pilgrims. It is expected that results of such studies will lead to implementation of evidence-based recommendations about preventive measures during the Hajj.

Dr Benkouiten is a researcher at the Institut Hospitalo–Universitaire Méditerranée Infection, Marseille, France. His research interests focus on the epidemiology of respiratory infections in the context of mass gatherings.

Top

Acknowledgment

This study was supported by The Marseille Public Hospitals Authority.

Top

References

  1. Ahmed  QA, Arabi  YM, Memish  ZA. Health risks at the Hajj. Lancet. 2006;367:100815. DOIPubMedGoogle Scholar
  2. Alzeer  AH. Respiratory tract infection during Hajj. Ann Thorac Med. 2009;4:503. DOIPubMedGoogle Scholar
  3. Alzahrani  AG, Choudhry  AJ, Al Mazroa  MA, Turkistani  AH, Nouman  GS, Memish  ZA. Pattern of diseases among visitors to Mina health centers during the Hajj season, 1429 H (2008 G). J Infect Public Health. 2012;5:2234. DOIPubMedGoogle Scholar
  4. Mandourah  Y, Al-Radi  A, Ocheltree  AH, Ocheltree  SR, Fowler  RA. Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj. BMC Infect Dis. 2012;12:117. DOIPubMedGoogle Scholar
  5. Benkouiten  S, Charrel  R, Belhouchat  K, Drali  T, Salez  N, Nougairede  A, Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clin Infect Dis. 2013;57:9921000. DOIPubMedGoogle Scholar
  6. Meysamie  A, Ardakani  HZ, Razavi  SM, Doroodi  T. Comparison of mortality and morbidity rates among Iranian pilgrims in Hajj 2004 and 2005. Saudi Med J. 2006;27:104953 .PubMedGoogle Scholar
  7. Deris  ZZ, Hasan  H, Sulaiman  SA, Wahab  MS, Naing  NN, Othman  NH. The prevalence of acute respiratory symptoms and role of protective measures among Malaysian hajj pilgrims. J Travel Med. 2010;17:828. DOIPubMedGoogle Scholar
  8. Balkhy  HH, Memish  ZA, Bafaqeer  S, Almuneef  MA. Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. J Travel Med. 2004;11:826. DOIPubMedGoogle Scholar
  9. Rashid  H, Shafi  S, Booy  R, El Bashir  H, Ali  K, Zambon  M, Influenza and respiratory syncytial virus infections in British Hajj pilgrims. Emerg Health Threats J. 2008;1:e2.
  10. Moattari  A, Emami  A, Moghadami  M, Honarvar  B. Influenza viral infections among the Iranian Hajj pilgrims returning to Shiraz, Fars province, Iran. Influenza Other Respir Viruses. 2012;6:e77–9.
  11. Memish  ZA, Assiri  AM, Hussain  R, Alomar  I, Stephens  G. Detection of respiratory viruses among pilgrims in Saudi Arabia during the time of a declared influenza A(H1N1) pandemic. J Travel Med. 2012;19:1521. DOIPubMedGoogle Scholar
  12. Benkouiten  S, Gautret  P, Belhouchat  K, Drali  T, Salez  N, Memish  ZA, Acquisition of Streptococcus pneumoniae carriage in pilgrims during the 2012 Hajj pilgrimage. Clin Infect Dis. 2014;58:e1069. DOIPubMedGoogle Scholar
  13. Gautret  P, Charrel  R, Belhouchat  K, Drali  T, Benkouiten  S, Nougairede  A, Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect. 2013;19:E3157. DOIPubMedGoogle Scholar
  14. Gautret  P, Charrel  R, Benkouiten  S, Belhouchat  K, Nougairede  A, Drali  T, Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014;20:72830. DOIPubMedGoogle Scholar
  15. Rashid  H, Shafi  S, El Bashir  H, Haworth  E, Memish  ZA, Ali  KA, Influenza and the Hajj: defining influenza-like illness clinically. Int J Infect Dis. 2008;12:1023. DOIPubMedGoogle Scholar
  16. van Elden  LJ, Nijhuis  M, Schipper  P, Schuurman  R, van Loon  AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol. 2001;39:196200. DOIPubMedGoogle Scholar
  17. Faux  C. Influenza type C. PCR methodology. In: Schuller M, Sloots TP, James GS, Halliday CL, Carter IW, editors. PCR for clinical microbiology: an Australian and international perspective. London: Springer; 2010. p. 311–2.
  18. Duchamp  MB, Casalegno  JS, Gillet  Y, Frobert  E, Bernard  E, Escuret  V, Pandemic A(H1N1)2009 influenza virus detection by real time RT-PCR: is viral quantification useful? Clin Microbiol Infect. 2010;16:31721. DOIPubMedGoogle Scholar
  19. Heim  A, Ebnet  C, Harste  G, Pring-Akerblom  P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol. 2003;70:22839. DOIPubMedGoogle Scholar
  20. Lu  X, Chittaganpitch  M, Olsen  SJ, Mackay  IM, Sloots  TP, Fry  AM, Real-time PCR assays for detection of bocavirus in human specimens. J Clin Microbiol. 2006;44:32315. DOIPubMedGoogle Scholar
  21. Griscelli  F, Barrois  M, Chauvin  S, Lastere  S, Bellet  D, Bourhis  JH. Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol. 2001;39:43629. DOIPubMedGoogle Scholar
  22. Tan  CY, Ninove  L, Gaudart  J, Nougairede  A, Zandotti  C, Thirion-Perrier  L, A retrospective overview of enterovirus infection diagnosis and molecular epidemiology in the public hospitals of Marseille, France (1985–2005). PLoS ONE. 2011;6:e18022. DOIPubMedGoogle Scholar
  23. Maertzdorf  J, Wang  CK, Brown  JB, Quinto  JD, Chu  M, de Graaf  M, Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol. 2004;42:9816. DOIPubMedGoogle Scholar
  24. Bennett  S, Harvala  H, Witteveldt  J, McWilliam Leitch  EC, McLeish  N, Templeton  K, Rapid simultaneous detection of enterovirus and parechovirus RNAs in clinical samples by one-step real-time reverse transcription-PCR assay. J Clin Microbiol. 2011;49:26204 and. DOIPubMedGoogle Scholar
  25. van Elden  LJ, van Loon  AM, van der Beek  A, Hendriksen  KA, Hoepelman  AI, van Kraaij  MG, Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults. J Clin Microbiol. 2003;41:437881. DOIPubMedGoogle Scholar
  26. Lu  X, Holloway  B, Dare  RK, Kuypers  J, Yagi  S, Williams  JV, Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses. J Clin Microbiol. 2008;46:5339. DOIPubMedGoogle Scholar
  27. Pillet  S, Lardeux  M, Dina  J, Grattard  F, Verhoeven  P, Le Goff  J, Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections. PLoS ONE. 2013;8:e72174. DOIPubMedGoogle Scholar
  28. Cohen-Bacrie  S, Ninove  L, Nougairède  A, Charrel  R, Richet  H, Minodier  P, Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care. PLoS ONE. 2011;6:e22403. DOIPubMedGoogle Scholar
  29. Memish  ZA, Assiri  A, Almasri  M, Alhakeem  RF, Turkestani  A, Al Rabeeah  AA, Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis. 2014. In press and. DOIPubMedGoogle Scholar
  30. Jacobs  SE, Lamson  DM, St George  K, Walsh  TJ. Human rhinoviruses. Clin Microbiol Rev. 2013;26:13562. DOIPubMedGoogle Scholar
  31. Graham  RL, Donaldson  EF, Baric  RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol. 2013;11:83648. DOIPubMedGoogle Scholar

Top

Figures
Tables

Top

Cite This Article

DOI: 10.3201/eid2011.140600

Table of Contents – Volume 20, Number 11—November 2014

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Philippe Gautret, Centre Hospitalier Universitaire Nord, Chemin des Bourrely, 13915 Marseille, France

Send To

10000 character(s) remaining.

Top

Page created: October 17, 2014
Page updated: October 17, 2014
Page reviewed: October 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external